Piezocatalytic Medicine: An Emerging Frontier using Piezoelectric Materials for Biomedical Applications
Advanced Materials · 2023-06 · 35 (25)
DOI: 10.1002/adma.202208256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 18.04.2023. Verfasst von Si Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Tenth People's Hospital, Clinical Center For Brain And Spinal Cord Research, Shanghai Frontiers Science Center of Nanocatalytic Medicine, Th…. Hauptthemen laut MEDLINE: Electrons, Sterilization. Die Arbeit wurde bisher 323-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation of China, Key Research Program of Frontier Sciences, Chinese Academy of Sciences.
Abstract (Originalsprache)
Emerging piezocatalysts have demonstrated their remarkable application potential in diverse medical fields. In addition to their ultrahigh catalytic activities, their inherent and unique charge‐carrier‐releasing properties can be used to initiate various redox catalytic reactions, displaying bright prospects for future medical applications. Triggered by mechanical energy, piezocatalytic materials can release electrons/holes, catalyze redox reactions of substrates, or intervene in biological processes to promote the production of effector molecules for medical purposes, such as decontamination, sterilization, and therapy. Such a medical application of piezocatalysis is termed as piezocatalytic medicine (PCM) herein. To pioneer novel medical technologies, especially therapeutic modalities, this review provides an overview of the state‐of‐the‐art research progress in piezocatalytic medicine. First, the principle of piezocatalysis and the preparation methodologies of piezoelectric materials are introduced. Then, a comprehensive summary of the medical applications of piezocatalytic materials in tumor treatment, antisepsis, organic degradation, tissue repair and regeneration, and biosensing is provided. Finally, the main challenges and future perspectives in piezocatalytic medicine are discussed and proposed, expecting to fuel the development of this emerging scientific discipline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Tenth People's Hospital, Clinical Center For Brain And Spinal Cord Research, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering and Nano Science, School of Med…
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics Chinese Academy of Sciences Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease,…
ORCID-Profile: Xiangyu Lu, Jianlin Shi
Förderung
- CAMS Innovation Fund for Medical Sciences
- National Natural Science Foundation of China
- Key Research Program of Frontier Sciences, Chinese Academy of Sciences
- Basic Research Program of Shanghai Municipal Government
- Fundamental Research Funds for the Central Universities
- Shanghai Municipal Health Commission
- National Key Research and Development Program of China
- Shanghai Blue Cross Brain Hospital Co., Ltd.
Zitieren
APA
Chen, S., Zhu, P., Mao, L., Wu, W., Lin, H., Xu, D., Lu, X., & Shi, J. (2023). Piezocatalytic Medicine: An Emerging Frontier using Piezoelectric Materials for Biomedical Applications. Advanced Materials, 35(25). https://doi.org/10.1002/adma.202208256
Vancouver
Chen S, Zhu P, Mao L, Wu W, Lin H, Xu D, et al. Piezocatalytic Medicine: An Emerging Frontier using Piezoelectric Materials for Biomedical Applications. Advanced Materials. 2023;35(25). doi:10.1002/adma.202208256
BibTeX
@article{Chen2023,
author = {Chen, Si and Zhu, Piao and Mao, Lijie and Wu, Wencheng and Lin, Han and Xu, Deliang and Lu, Xiangyu and Shi, Jianlin},
title = {Piezocatalytic Medicine: An Emerging Frontier using Piezoelectric Materials for Biomedical Applications},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {25},
doi = {10.1002/adma.202208256}
}
EUVIMED